HIV infections in northwestern Cameroon: Identification of HIV type 1 group O and dual HIV type 1 group M and group O infections

AIDS Research and Human Retroviruses

Volumn 20, Issue 9, 2004, Pages 944-957

  Yamaguchi, Julie ^a   Bodelle, Pierre ^a   Vallari, Ana S ^a   Coffey, Ruthie ^a   McArthur, Carole P ^b   Schochetman, Gerald ^a   Devare, Sushil G ^a   Brennan, Catherine A ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CAMEROON; GENE AMPLIFICATION; GENETIC RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; VIRUS IDENTIFICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; CAMEROON; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; PEPTIDE FRAGMENTS; PEPTIDES; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEROTYPING; SIMIAN IMMUNODEFICIENCY VIRUS; VARIATION (GENETICS);

EID: 5644287537     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.944     Document Type: Article

References (33)

1. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, and Hahn BH: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
2. Peeters M and Courgnaud V: Overview of primate lentiviruses and their evolution in non-human primates in Africa. In: HIV Sequence Compendium 2002 (Kuiken C, Foley B, Freed E, Hahn B, Marx PA, McCutchan F, Mellors JW, Wolinksy S, and Korber B, eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2003, pp. 2-23.
3. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, Learn GH, Leitner T, McCutchan F, Osmanov S, Peeters M, Pieniazek D, Salminen M, Sharp PM, Wolinsky S, and Korber B: HIV-1 Nomenclature Proposal A reference guide to HIV-1 classification. In: Human Retroviruses and AIDS 1999 (Kuiken C, McCutchan F, Foley B, Mellors JW, Hahn B, Mullins J, Marx P, and Wolinsky S, eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 1999, pp. 492-505.
4. Peeters M: Recombinant HIV sequences: Their role in the global epidemic. In: HIV Sequence Compendium 2000 (Kuiken CL, Foley B, Hahn B, Marx PA, McCutchan F, Mellors JW, Mullins JI, Sodroski J, Wolinksy S, and Korber B, eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2000, pp. 54-72.
5. Yamaguchi J, Vallari A, Swanson P, Bodelle P, Kaptué L, Ngansop C, Zekeng L, Gürtler LG, Devare SG, and Brennan CA: Evaluation of HIV type 1 group O isolates: Identification of five phylogenetic clusters. AIDS Res Hum Retroviruses 2002;18:269-282.
6. Yamaguchi J, Bodelle P, Kaptué L, Zekeng L, Gértler LG, Devare SG, and Brennan CA: Near full-length genomes of 15 HIV Type 1 group O isolates. AIDS Res Hum Retroviruses 2003;19:979-988.
7. Takehisa J, Zekeng L, Ido E, Yamaguchi-Kabata Y, Mboudjeka I, Harada Y, Miura T, Kaptuè L, and Hayami M: Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-6820.
8. Peeters M, Liegeois F, Torimiro N, Bourgeois A, Mpoudi E, Vergne L, Saman E, Delaporte E, and Saragosti S: Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7369-7375.
9. Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, Laurent C, Butel C, Zekeng L, Delaporte E, and Peeters M: Biological and genetic characterization of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 2003;310: 254-266.
10. Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Nkengasong JN, Gao F, Rayfield M, Folks TM, Pieniazek D, and Lal RB: Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res Hum Retroviruses 2000;16:1319-1324.
11. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, et al.: Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J Virol 2000;74:363-370.
12. Heyndrickx L, Janssens W, Ndumbe PM, Vereecken K, Coppens S, De Houwer K, Fransen K, Van der Auwera G, and van der Groen G: HIV-1 genetic variability in Cameroon. AIDS 2000;14:1862-1864.
13. Carr JK, Torimiro JN, Wolfe ND, Eitel MN, Kim B, Sanders-Buell E, Jagodzinski LL, Gotte D, Burke DS, Birx DL, and McCutchan FE: The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology 2001;286:168-181.
14. Laurent C, Bourgeois A, Awa Faye M, Mougnutou R, Seydi M, Gueye M, Liegéois F, Touré Kane C, Butel C, Mbuagbaw J, Zekeng L, Mboup S, Mpoudi-Ngol[e] E, Peeters M, and Delaporte E: No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in western and west-central Africa: A four year prospective multicenter study, J Infect Dis 2002;186:486-492.
15. Nyambi P, Heyndrickx L, Vereecken K, Burda S, De Houwer K, Coppens S, Urbanski M, Williams C, Ndumbe P, and Janssens W: Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 2002;16:295-296.
16. Zhong P, Burda S, Urbanski M, Kenfack H, Tongo M, Heyndrickx L, Nanfack A, Shang J, Agyingi L, Zolla-Pazner S, Zekeng L, and Nyambi P: HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon. J Acquir Immune Defic Syndr 2002;31:495-505.
17. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptué L: A new subtype of human immunodeficiency virus type 1 (MVP5180) from Cameroon. J Virol 1994;68:1581-1585.
18. Peeters M, Gueye A, Mboup S, Bibollet-Ruche F, Ekaza E, Mulanga C, Ouedrago R, Gandji R, Mpele P, Dibanga G, Koumare B, Saidou M, Esu-Williams E, Lombart J-P, Badombena W, Luo N, Vanden Haesevelde M, and Delaporte E: Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997;11:493-498.
19. Ayouba A, Mauclère P, Martin PM, Cunin P, Mfoupouendoun J, Njinku B, Souquieres S, and Simon F: HIV-1 group O infections in Cameroon, 1986-1998. Emerg Infect Dis 2001;7:466-467.
20. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, and Brun-Vézinet F: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-1037.
21. Ayouba A, Souquières S, Njinku B, Martin PMV, Müller-Trutwin MC, Roques P, Barré-Sinoussi F, Mauclère P, Simon F, and Nerrienet E: HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS 2000;14:2623-2625.
22. Vallari AS, Hickman RK, Hackett JR, Brennan CA, Varitek VA, and Devare SG: Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2. J Clin Microb 1998;36:3657-3661.
23. Brennan CA, Lund JK, Golden A, Yamaguchi J, Vallari AS, Phillips JF, Kataaha PK, Jackson JB, and Devare SG: Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda. AIDS 1997;11:1823-1832.
24. Swanson P, Devare SG, and Hackett J: Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: Sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 2003;19:625-629.
25. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, Brun-Vézinet, F, and Simon F: HIV-1/HIV-2 sero-negativity in HIV-1 subtype O infected patients. Lancet 1994;343: 1393-1394.
26. Simon, F, Ly TD, Baillou-Beaufils A, Fauveau V, De Saint-Martin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Couroucé AM, Ingrand D, Janot C, and Brun-Vézinet, F: Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS 1994;8:1628-1629.
27. Schable C, Zekeng L, Pau C-P, Hu D, Kaptué L, Gürtler L, Dondero T, Tsague J-M, Schochetman G, Jaffe H, and George JR: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-1334.
28. Gürtler LG, Zeleng L, Simon F, Eberle J, Tsague JM, Kaptué L, Brust S, and Knapp S: Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots. J Virol Methods 1995;51:177-184.
29. Tebit DM, Zekeng L, Kaptué L, Salminen M, Kräusslich H-G, and Herchenröder O: Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 2002;18:39-48.
30. Takehisa J, Zekeng L, Ido E, Mboudjeka I, Moriyama H, Miura T, Yamashita M, Gürtler LG, Hayami M, and Kaptué L: Various types of HIV mixed infections in Cameroon. Virology 1998;245:1-10.
31. Roques P, Robertson DL, Souquière S, Damond F, Ayouba A, Farfara I, Depienne C, Nerrienet E, Dormont D, Brun-Vézinet F, Simon F, and Mauclère P: Phylogenetic analysis of 49 newly derived HIV-1 group O strains: High genetic diversity but no group M-like subtype structure. Virology 2002;302:259-273.
32. Swanson P, Soriano V, Devare SG, and Hackett J: Comparative performance of three viral load assays on human immunodeficiency viras type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR Version 1.5 and Quantiplex HIV-1 RNA Version 3.0. J Clin Microbiol 2001;39:862-870.
33. Jagodzinski LL, Cooley JD, Weber M, and Micael NL: Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B. J Clin Microbiol 2003; 41:998-1003.